+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmacy Market Size, Share & Trends Analysis Report by Product (Prescription, OTC), Type (Hospital Pharmacy, Retail Pharmacy (Chain, Independent, Others), EPharmacy, Others), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 142 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 5526480
The Pharmacy Market was valued at USD 1.35 trillion in 2024, and is projected to reach USD 2.06 trillion by 2030, rising at a CAGR of 7.30%. The rising prevalence of chronic diseases, increasing market penetration of online pharmacy services, and the entry of global retail companies into this market are primarily driving the growth.

Increasing investments by key market participants in improving presence across various regions, collaborations among companies, and rising adoption of online pharmacy services that offer convenience and cost savings are expected to fuel further growth of this market. The growing incident rate of accidents leading to higher demand for OTC drugs and the growth experienced by the prescription medicine segment, primarily due to enhanced diagnostic technologies and imaging techniques, are likely to develop strong growth opportunities over the forecast period.

Adoption of advanced technologies for enhanced processes and service delivery, availability of various software solutions developed for pharmacy industry participants, and increasing ubiquity of smartphone devices, which facilitates the growth of ePharmacy services, also contribute to the advancements experienced by this market. Collaborations among key companies, the growing digital footprint of online pharmacies, and the focus of numerous key market participants on enhancing global presence also influence this market.

Pharmacy Market Report Highlights

  • On the basis of products, the prescription segment dominated the global pharmacy industry and accounted for over 80% of the revenue share in 2024, owing to the rising occurrence of chronic illnesses such as cancer, diabetes, and cardiovascular diseases.
  • The OTC segment is projected to experience the fastest growth over the forecast period.
  • The retail pharmacy segment held the largest revenue share of the pharmacy industry, owing to the entry of multiple global retail companies in the pharmacy business, a vast network of retail pharmacy stores operated by key players, and the growth experienced by online retail pharmacy.
  • The ePharmacy segment is anticipated to experience the fastest growth over the forecast period.
  • North America dominated the global pharmacy industry with a revenue share of more than 50% in 2024, owing to various pharmaceutical manufacturing companies operating in the region and large retail pharmacy chains providing services across multiple locations, especially in the U.S.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product segment
1.2.2. Type segment
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Type outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Pharmacy Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Pharmacy Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
Chapter 4. Pharmacy Market: Product Estimates & Trend Analysis
4.1. Product Segment Dashboard
4.2. Pharmacy Market: Product Movement Analysis
4.3. Global Pharmacy Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Prescription
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. OTC
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Pharmacy Market: Type Estimates & Trend Analysis
5.1. Type Segment Dashboard
5.2. Pharmacy Market: Type Movement Analysis
5.3. Global Pharmacy Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
5.4. Hospital Pharmacy
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Retail Pharmacy
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. Chain
5.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5.3. Independent
5.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5.4. Others
5.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. ePharmacy
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Pharmacy Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. Continuous bioprocessing market by Region: Key Takeaways
6.4. North America
6.4.1. U.S.
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Canada
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Mexico
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Europe
6.5.1. UK
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Germany
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. France
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Italy
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. Spain
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Norway
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.5.7. Sweden
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. China
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. India
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Australia
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Thailand
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. Argentina
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Saudi Arabia
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. UAE
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.8.4. Kuwait
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework/ reimbursement structure
6.8.4.3. Competitive scenario
6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key company heat map analysis, 2024
7.4. Company Profiles
7.4.1. CVS Health
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Boots Walgreens
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Walmart Inc.
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. The Kroger Co.
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Rite Aid Corp.
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. MCKESSON CORPORATION
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Well Pharmacy
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Humana
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Matsumotokiyoshi Co., Ltd.
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Apollo Pharmacy
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. MedPlusMart.com
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. Amazon
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global pharmacy market, by region, 2018-2030 (USD Million)
Table 3 Global pharmacy market, by product, 2018-2030 (USD Million)
Table 4 Global pharmacy market, by type, 2018-2030 (USD Million)
Table 5 North America pharmacy market, by country, 2018-2030 (USD Million)
Table 6 North America pharmacy market, by product, 2018-2030 (USD Million)
Table 7 North America pharmacy market, by type, 2018-2030 (USD Million)
Table 8 U.S. pharmacy market, by product, 2018-2030 (USD Million)
Table 9 U.S. pharmacy market, by type, 2018-2030 (USD Million)
Table 10 Canada pharmacy market, by product, 2018-2030 (USD Million)
Table 11 Canada pharmacy market, by type, 2018-2030 (USD Million)
Table 12 Mexico pharmacy market, by product, 2018-2030 (USD Million)
Table 13 Mexico pharmacy market, by type, 2018-2030 (USD Million)
Table 14 Europe pharmacy market, by country, 2018-2030 (USD Million)
Table 15 Europe pharmacy market, by product, 2018-2030 (USD Million)
Table 16 Europe pharmacy market, by type, 2018-2030 (USD Million)
Table 17 Germany pharmacy market, by product, 2018-2030 (USD Million)
Table 18 Germany pharmacy market, by type, 2018-2030 (USD Million)
Table 19 UK pharmacy market, by product, 2018-2030 (USD Million)
Table 20 UK pharmacy market, by type, 2018-2030 (USD Million)
Table 21 France pharmacy market, by product, 2018-2030 (USD Million)
Table 22 France pharmacy market, by type, 2018-2030 (USD Million)
Table 23 Italy pharmacy market, by product, 2018-2030 (USD Million)
Table 24 Italy pharmacy market, by type, 2018-2030 (USD Million)
Table 25 Spain pharmacy market, by product, 2018-2030 (USD Million)
Table 26 Spain pharmacy market, by type, 2018-2030 (USD Million)
Table 27 Denmark pharmacy market, by product, 2018-2030 (USD Million)
Table 28 Denmark pharmacy market, by type, 2018-2030 (USD Million)
Table 29 Sweden pharmacy market, by product, 2018-2030 (USD Million)
Table 30 Sweden pharmacy market, by type, 2018-2030 (USD Million)
Table 31 Norway pharmacy market, by product, 2018-2030 (USD Million)
Table 32 Norway pharmacy market, by type, 2018-2030 (USD Million)
Table 33 Asia Pacific pharmacy market, by country, 2018-2030 (USD Million)
Table 34 Asia Pacific pharmacy market, by product, 2018-2030 (USD Million)
Table 35 Asia Pacific pharmacy market, by type, 2018-2030 (USD Million)
Table 36 China pharmacy market, by product, 2018-2030 (USD Million)
Table 37 China pharmacy market, by type, 2018-2030 (USD Million)
Table 38 Japan pharmacy market, by product, 2018-2030 (USD Million)
Table 39 Japan pharmacy market, by type, 2018-2030 (USD Million)
Table 40 India pharmacy market, by product, 2018-2030 (USD Million)
Table 41 India pharmacy market, by type, 2018-2030 (USD Million)
Table 42 South Korea pharmacy market, by product, 2018-2030 (USD Million)
Table 43 South Korea pharmacy market, by type, 2018-2030 (USD Million)
Table 44 Australia pharmacy market, by product, 2018-2030 (USD Million)
Table 45 Australia pharmacy market, by type, 2018-2030 (USD Million)
Table 46 Thailand pharmacy market, by product, 2018-2030 (USD Million)
Table 47 Thailand pharmacy market, by type, 2018-2030 (USD Million)
Table 48 Latin America pharmacy market, by country, 2018-2030 (USD Million)
Table 49 Latin America pharmacy market, by product, 2018-2030 (USD Million)
Table 50 Latin America pharmacy market, by type, 2018-2030 (USD Million)
Table 51 Latin America pharmacy market, by type, 2018-2030 (USD Million)
Table 52 Brazil pharmacy market, by product, 2018-2030 (USD Million)
Table 53 Brazil pharmacy market, by type, 2018-2030 (USD Million)
Table 54 Argentina pharmacy market, by product, 2018-2030 (USD Million)
Table 55 Argentina pharmacy on market, by type, 2018-2030 (USD Million)
Table 56 MEA pharmacy market, by region, 2018-2030 (USD Million)
Table 57 MEA pharmacy market, by product, 2018-2030 (USD Million)
Table 58 MEA pharmacy market, by type, 2018-2030 (USD Million)
Table 59 South Africa pharmacy market, by product, 2018-2030 (USD Million)
Table 60 South Africa pharmacy market, by type, 2018-2030 (USD Million)
Table 61 Saudi Arabia pharmacy market, by product, 2018-2030 (USD Million)
Table 62 Saudi Arabia pharmacy market, by type, 2018-2030 (USD Million)
Table 63 UAE pharmacy market, by product, 2018-2030 (USD Million)
Table 64 UAE pharmacy market, by type, 2018-2030 (USD Million)
Table 65 Kuwait pharmacy market, by product, 2018-2030 (USD Million)
Table 66 Kuwait pharmacy market, by type, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Pharmacy market: Market outlook
Figure 10 Pharmacy competitive insights
Figure 11 Parent market outlook
Figure 12 Related/ancillary market outlook
Figure 13 Penetration and growth prospect mapping
Figure 14 Industry value chain analysis
Figure 15 Pharmacy market driver impact
Figure 16 Pharmacy market restraint impact
Figure 17 Pharmacy market strategic initiatives analysis
Figure 18 Pharmacy market: Product movement analysis
Figure 19 Pharmacy market: Product outlook and key takeaways
Figure 20 Prescription products market estimates and forecast, 2018-2030
Figure 21 OTC products market estimates and forecast, 2018-2030
Figure 22 Pharmacy market: Type movement Analysis
Figure 23 Pharmacy market: Type outlook and key takeaways
Figure 24 Hospital pharmacy market estimates and forecasts, 2018-2030
Figure 25 Retail pharmacy market estimates and forecasts, 2018-2030
Figure 26 Chain retail pharmacy market estimates and forecasts, 2018-2030
Figure 27 Independent retail pharmacy market estimates and forecasts, 2018-2030
Figure 28 Other retail pharmacies market estimates and forecasts, 2018-2030
Figure 29 epharmacy market estimates and forecasts, 2018-2030
Figure 30 Other pharmacy market estimates and forecasts, 2018-2030
Figure 31 Global pharmacy market: Regional movement analysis
Figure 32 Global pharmacy market: Regional outlook and key takeaways
Figure 33 North America market estimates and forecasts, 2018-2030
Figure 34 U.S. market estimates and forecasts, 2018-2030
Figure 35 Canada market estimates and forecasts, 2018-2030
Figure 36 Mexico market estimates and forecasts, 2018-2030
Figure 37 Europe market estimates and forecasts, 2018-2030
Figure 38 UK market estimates and forecasts, 2018-2030
Figure 39 Germany market estimates and forecasts, 2018-2030
Figure 40 France market estimates and forecasts, 2018-2030
Figure 41 Italy market estimates and forecasts, 2018-2030
Figure 42 Spain market estimates and forecasts, 2018-2030
Figure 43 Denmark market estimates and forecasts, 2018-2030
Figure 44 Sweden market estimates and forecasts, 2018-2030
Figure 45 Norway market estimates and forecasts, 2018-2030
Figure 46 Asia Pacific market estimates and forecasts, 2018-2030
Figure 47 China market estimates and forecasts, 2018-2030
Figure 48 Japan market estimates and forecasts, 2018-2030
Figure 49 India market estimates and forecasts, 2018-2030
Figure 50 Thailand market estimates and forecasts, 2018-2030
Figure 51 South Korea market estimates and forecasts, 2018-2030
Figure 52 Australia market estimates and forecasts, 2018-2030
Figure 53 Latin America market estimates and forecasts, 2018-2030
Figure 54 Brazil market estimates and forecasts, 2018-2030
Figure 55 Argentina market estimates and forecasts, 2018-2030
Figure 56 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 57 South Africa market estimates and forecasts, 2018-2030
Figure 58 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 59 UAE market estimates and forecasts, 2018-2030
Figure 60 Kuwait market estimates and forecasts, 2018-2030

Companies Mentioned

The major companies featured in this Pharmacy market report include:
  • Boots Walgreens
  • Walmart Inc.
  • The Kroger Co.
  • Rite Aid Corp.
  • MCKESSON CORPORATION
  • Well Pharmacy
  • Humana
  • Matsumotokiyoshi Co., Ltd.
  • Apollo Pharmacy
  • MedPlusMart.com
  • Amazon

Table Information